DE Burlo Group Inc. cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.3% during the second quarter, Holdings Channel reports. The firm owned 24,820 shares of the company’s stock after selling 590 shares during the period. DE Burlo Group Inc.’s holdings in Henry Schein were worth $4,542,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. Comerica Bank increased its stake in Henry Schein by 10.6% in the second quarter. Comerica Bank now owns 21,833 shares of the company’s stock valued at $4,054,000 after buying an additional 2,101 shares during the period. Legal & General Group Plc increased its stake in Henry Schein by 5.1% in the second quarter. Legal & General Group Plc now owns 479,798 shares of the company’s stock valued at $87,814,000 after buying an additional 23,424 shares during the period. WASHINGTON TRUST Co increased its stake in Henry Schein by 1,570.9% in the second quarter. WASHINGTON TRUST Co now owns 24,612 shares of the company’s stock valued at $4,505,000 after buying an additional 23,139 shares during the period. LMR Partners LLP bought a new stake in Henry Schein during the second quarter valued at $778,000. Finally, Dupont Capital Management Corp increased its stake in Henry Schein by 29.5% in the second quarter. Dupont Capital Management Corp now owns 56,521 shares of the company’s stock valued at $10,344,000 after buying an additional 12,874 shares during the period. 90.60% of the stock is owned by hedge funds and other institutional investors.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 170.31 on Thursday. The company has a market capitalization of $13.46 billion, a P/E ratio of 24.89 and a beta of 1.09. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The firm has a 50-day moving average of $180.27 and a 200-day moving average of $175.46. Henry Schein shares are set to split on the morning of Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly minted shares will be distributed to shareholders after the market closes on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period last year, the company posted $1.64 EPS. Henry Schein’s revenue was up 6.4% on a year-over-year basis. On average, equities analysts predict that Henry Schein, Inc. will post $7.27 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/17/henry-schein-inc-hsic-shares-sold-by-de-burlo-group-inc.html.

Several equities research analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target for the company in a research note on Monday, August 7th. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reissued a “hold” rating and set a $177.00 target price on shares of Henry Schein in a research report on Friday, July 21st. Finally, Credit Suisse Group reissued a “hold” rating and set a $160.00 target price on shares of Henry Schein in a research report on Thursday, July 13th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and an average price target of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.